Senescent cancer cell-derived nanovesicle as a personalized therapeutic cancer vaccine

The development of therapeutic cancer vaccines (TCVs) that provide clinical benefits is challenging mainly due to difficulties in identifying immunogenic tumor antigens and effectively inducing antitumor immunity. Furthermore, there is an urgent need for personalized TCVs because only a limited numb...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Jihye, Jung, Mungyo, Kim, Cheesue, Kang, Mikyung, Go, Seokhyeong, Sohn, Heesu, Moon, Sangjun, Kwon, Sungpil, Song, Seuk Young, Kim, Byung-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073290/
https://www.ncbi.nlm.nih.gov/pubmed/36854774
http://dx.doi.org/10.1038/s12276-023-00951-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073290/
https://www.ncbi.nlm.nih.gov/pubmed/36854774
http://dx.doi.org/10.1038/s12276-023-00951-z

Ejemplares similares